DAX22.840 -2,8%Est505.614 -2,1%MSCI World4.343 -0,1%Top 10 Crypto9,2900 -3,2%Nas22.162 ±0,0%Bitcoin60.352 -2,9%Euro1,1607 +1,3%Öl106,3 -3,1%Gold4.652 -3,8%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Vonovia A1ML7J Rheinmetall 703000 Siemens Energy ENER6Y SAP 716460 NVIDIA 918422 Lufthansa 823212 DroneShield A2DMAA Volkswagen (VW) vz. 766403 Deutsche Telekom 555750 Allianz 840400 Infineon 623100 Micron Technology 869020 Shell (ex Royal Dutch Shell) A3C99G Deutsche Bank 514000 Commerzbank CBK100
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nach EZB-Zinsentscheid: DAX schließt tiefrot -- Wall Street schwach -- Micron-Zahlen: Gewinn vervielfacht -- Equinor, Rivian, Uber, Samsung, Rüstungsaktien, Siemens Energy, Tesla, NVIDIA, BYD im Fokus
Top News
Kommt die Cerebras-Aktie im April? NVIDIA-Herausforderer vor Börsengang unter der Lupe Kommt die Cerebras-Aktie im April? NVIDIA-Herausforderer vor Börsengang unter der Lupe
Nach EZB-Entscheid: DAX schließt tief im Minus - 23.000er-Marke unterschritten - Steigender Ölpreis im Fokus Nach EZB-Entscheid: DAX schließt tief im Minus - 23.000er-Marke unterschritten - Steigender Ölpreis im Fokus
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Noch bis 13. April bei der Commerzbank gebührenfrei in Vanguard-ETFs investieren
Wer­bung

Boston Scientific Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
60,80 EUR -1,20 EUR -1,94 %
STU
70,59 USD -0,69 USD -0,97 %
BTT
finanzen.net zero
Boston Scientific jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.92,30 Mrd. EUR

KGV49,17Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN884113

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS1011371077

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolBSX

Boston Scientific Aktien News

DatumMeistgelesen
PR NewswireBoston Scientific Announces Agreement to Acquire Valencia Technologies Corporation
PR NewswireBoston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results
PR NewswireBoston Scientific announces upcoming investor conference schedule
Wer­bungBoston Scientific-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireBoston Scientific announces results for third quarter 2025
PR NewswireBoston Scientific Announces Agreement to Acquire Nalu Medical, Inc.
PR NewswireBoston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results
PR NewswireBoston Scientific announces results for second quarter 2025
PR NewswireBoston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System
PR NewswireBoston Scientific announces conference call discussing second quarter 2025 results
PR NewswireBoston Scientific announces upcoming investor conference schedule
PR NewswireSecond phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints
PR NewswireBoston Scientific Chief Financial Officer (CFO) Dan Brennan to retire; Jon Monson, senior vice president, Investor Relations to succeed Brennan
PR NewswireBoston Scientific announces results for first quarter 2025
PR NewswireBoston Scientific announces conference call discussing first quarter 2025 results
PR NewswireBoston Scientific announces agreement to acquire SoniVie Ltd.
PR NewswireBoston Scientific to participate in TD Cowen's 45th Annual Health Care Conference
PR NewswireBoston Scientific announces results for fourth quarter and full year 2024
PR NewswireLate-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation
PR NewswireBoston Scientific Announces Agreement to Acquire Bolt Medical, Inc.
PR NewswireBoston Scientific Announces Participation in the J.P. Morgan Healthcare Conference and Conference Call Discussing Fourth Quarter 2024 Results
PR NewswireBoston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace
PR NewswireBoston Scientific Announces Agreement to Acquire Intera Oncology® Inc.
PR NewswireBoston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial
PR NewswireBoston Scientific Closes Acquisition of Axonics, Inc.
PR NewswireBoston Scientific to Participate in the 2024 UBS Global Healthcare Conference
PR NewswireBoston Scientific Announces Agreement to Acquire Cortex, Inc.
PR NewswireACURATE neo2™ Aortic Valve System Data Presented at Late-Breaking Clinical Trial Session at TCT 2024
PR NewswireBoston Scientific Announces Results for Third Quarter 2024
PR NewswireBoston Scientific Launches Next Generation of Cardiac Mapping for the FARAPULSE™ Pulsed Field Ablation System
PR NewswireBoston Scientific Announces Conference Call Discussing Third Quarter 2024 Results
PR NewswireBoston Scientific Receives Japanese Regulatory Approval for the FARAPULSE™ Pulsed Field Ablation System
PR NewswireBoston Scientific Closes Acquisition of Silk Road Medical, Inc.
PR NewswireBoston Scientific Receives FDA Approval for Expanded Indication of INGEVITY™+ Pacing Leads to Include Conduction System Pacing of the Left Bundle Branch Area
PR NewswireBoston Scientific Obtains CE Mark for ACURATE Prime™ Aortic Valve System
PR NewswireBoston Scientific to Participate in Wells Fargo's 2024 Healthcare Conference
PR NewswireBoston Scientific Elects David Habiger to Board of Directors
PR NewswireBoston Scientific Announces Results for Second Quarter 2024
PR NewswireBoston Scientific Announces Conference Call Discussing Second Quarter 2024 Results
PR NewswireALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc.
PR NewswireBoston Scientific Announces Agreement to Acquire Silk Road Medical, Inc.

Boston Scientific News

Boston Scientific News: auf dieser Seite finden Sie alle Boston Scientific News und Nachrichten zur Boston Scientific Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Boston Scientific News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Boston Scientific News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.